Clinical trial
Exploratory Phase II Study of LAnreotide in Metastatic Pheochromocytoma/PARAganglioma (LAMPARA)
NCT03946527 is registered in ClinicalTrials.gov with Antonio Fojo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Phase II Study of LAnreotide in Metastatic Pheochromocytoma/PARAganglioma (LAMPARA)
- Lead sponsor
- Antonio Fojo
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- June 17, 2019
- Completion date
- March 31, 2027
- Enrollment
- 10 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.